This case report depicts a probable infusion reaction in a 61-year-old woman prescribed evinacumab for the treatment of familial hypercholesterolemia.
Geena Eglin, PharmD, BCACP, CSP, CPP
Advertisement
Articles by Geena Eglin, PharmD, BCACP, CSP, CPP
The extra surveillance by a specialty pharmacy teams allows for faster initiation of therapy, earlier recognition of adverse effects, and promotes patient safety.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Therapeutic Cancer Vaccines: Are We There Yet?
2
Transforming HER2+ Metastatic Breast Cancer Treatment With Targeted ADC Therapy
3
Walgreens Strengthens Vaccine Access Through Digital Tools, Pharmacist Education
4
Subcutaneous Amivantamab Shows Promise in EGFR-Mutated Lung Cancer
5
